Flavoxate Hydrochloride is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Tagi Pharma, Inc.. The primary component is Flavoxate Hydrochloride.
| Product ID | 51224-154_34c3850c-1be2-4a78-9339-b2647a94cc3a |
| NDC | 51224-154 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Flavoxate Hydrochloride |
| Generic Name | Flavoxate Hydrochloride |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-03-25 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA076835 |
| Labeler Name | TAGI Pharma, Inc. |
| Substance Name | FLAVOXATE HYDROCHLORIDE |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2011-03-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA076835 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-03-25 |
| Marketing End Date | 2020-03-31 |
| Marketing Category | ANDA |
| Application Number | ANDA076835 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-03-25 |
| Marketing End Date | 2020-03-31 |
| Ingredient | Strength |
|---|---|
| FLAVOXATE HYDROCHLORIDE | 100 mg/1 |
| SPL SET ID: | 5cc7ad48-0918-444d-a97e-64c43852f3a6 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0574-0115 | FLAVOXATE HYDROCHLORIDE | FLAVOXATE HYDROCHLORIDE |
| 24658-720 | Flavoxate Hydrochloride | Flavoxate Hydrochloride |
| 42806-058 | Flavoxate Hydrochloride | Flavoxate Hydrochloride |
| 50268-324 | Flavoxate Hydrochloride | Flavoxate Hydrochloride |
| 51224-154 | Flavoxate Hydrochloride | Flavoxate hydrochloride |
| 68151-3826 | FLAVOXATE HYDROCHLORIDE | FLAVOXATE HYDROCHLORIDE |